Results 181 to 190 of about 149,361 (217)

Hematopoietic Stem Cell Transplantation for Myelofibrosis

Seminars in Oncology, 2005
Myelofibrosis with myeloid metaplasia (MMM) is a clonal disorder resulting from the proliferation of aberrant hematopoietic progenitors. Hence MMM is curable if the abnormal clone can be eradicated and replaced by normal cells from healthy donors.
Koen, van Besien, H Joachim, Deeg
openaire   +2 more sources

Hematopoietic Stem Cell Transplantation for Thalassemia

Current Stem Cell Research & Therapy, 2009
Hematopoietic stem cell transplantation (HSCT) represents the only cure for patients with thalassemia. At present HSCT in younger patients from an HLA- matched sibling donor offers 80% to 87% probability of cure according to risk classes. However, results HSCT in adult patients continue to be inferior due to advanced of disease.
Javid, Gaziev, Guido, Lucarelli
openaire   +2 more sources

Transplantation of hematopoietic stem cells in utero

Stem Cells, 1997
Hematopoietic stem cell (HSC) transplantation in children and adults with congenital lymphohematopoietic disorders is limited by donor availability, graft failure, graft-versus-host disease (GVHD) and delayed immunological reconstitution. These problems may be circumvented by transplanting the patient before birth.
E D, Zanjani, G, Almeida-Porada, J L, Ascensao, F R, MacKintosh, A W, Flake   +4 more
openaire   +2 more sources

Spousal hematopoietic stem cell transplantation

International Journal of Hematology, 2016
We report a pilot series of five patients who received stem cell transplantation (SCT) from a spouse for post-transplant relapse or rejection. The inclusion criterion regarding HLA disparities was three or fewer antigen mismatches in the graft-versus-host direction at the HLA-A, B, and DR loci.
Kazuhiro, Ikegame, Katsuji, Kaida, Satoshi, Yoshihara, Kyoko, Yoshihara, Shinichi, Ishii, Takayuki, Inoue, Masaya, Okada, Hiroya, Tamaki, Toshihiro, Soma, Yasushi, Kusunoki, Hiroto, Kojima, Hiroh, Saji, Hiroyasu, Ogawa   +12 more
openaire   +2 more sources

History of Hematopoietic Stem Cell Transplantation

Seminars in Oncology Nursing, 2009
To provide an overview of the history of hematopoietic stem cell transplantation (HSCT).Research studies, book chapters, websites, and articles.The history of HSCT begins in the late 1950s. Although many treatment strategies have evolved, the basic concepts of transplantation remain the same.An understanding of the history of HSCT and transplant ...
openaire   +2 more sources

Immunology of Hematopoietic Stem Cell Transplant

Immunological Investigations, 2014
Hematopoietic stem cell transplantation (HSCT) is a procedure in which infusion of hematopoietic stem cells is used to reestablish hematopoietic function in patients with damaged or defective bone marrow or immune systems. Early and late complications following allogeneic HSCT include acute and chronic graft-versus-host disease (GVHD), donor rejection,
openaire   +2 more sources

Hematopoietic Stem Cell Transplantation

Clinical Journal of Oncology Nursing, 2004
Nonniekaye Shelburne, Margaret Bevans, William P. Hogle   +2 more
openaire   +4 more sources

An Overview of Hematopoietic Stem Cell Transplantation

Clinics in Chest Medicine, 2005
This article is a broad overview of hematopoietic stem cell transplantation, covering topics such as indications for transplantation, types of transplantation procedures, HLA matching of donors and recipients, procurement of stem cells from donors, and outcomes of transplantation.
Corey, Cutler, Joseph H, Antin
openaire   +2 more sources

Hematopoietic Stem Cell Transplantation for Osteopetrosis

Pediatric Clinics of North America, 2010
Osteopetrosis is the generic name for a group of diseases caused by deficient formation or function of osteoclasts, inherited in either autosomal recessive or dominant fashion. Osteopetrosis varies in severity from a disease that may kill infants to an incidental radiological finding in adults.
openaire   +2 more sources

Radioimmunoconjugates in Hematopoietic Stem Cell Transplantation

2008
s, 2006;330). 38. Gisselbrecht C, Decaudin D, Mounier N, Tilly H, et al. 90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory follicular lymphoma. GELA Phase II Study. Blood (ASH Annual Meeting Abstracts), Nov 2007;110:22. 39.
Ajay K, Gopal, Jane N, Winter
openaire   +2 more sources